G - Physics – 01 – N
Patent
G - Physics
01
N
G01N 33/574 (2006.01)
Patent
CA 2530479
The present invention relates to the diagnosis of colorectal cancer. It discloses the use of protein PSE3 (proteasome activator subunit 3) in the diagnosis of colorectal cancer. It relates to a method for diagnosis of colorectal cancer from a liquid sample, derived from an individual by measuring PSE3 in said sample. Measurement of PSE3 can, e.g., be used in the early detection or diagnosis of colorectal cancer.
La présente invention concerne le diagnostic du cancer colorectal au moyen de la protéine PSE3. La protéine PSE3 est mesurée dans un échantillon liquide prélevé sur un individu. Cette mesure permet de détecter ou de diagnostiquer précocement un cancer colorectal.
Berndt Peter
Hagmann Marie-Luise
Karl Johann
Langen Hanno
Palme Stefan
Borden Ladner Gervais Llp
F. Hoffmann-La Roche Ag
LandOfFree
Use of protein proteasome activator subunit 3 (pse3) as a... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of protein proteasome activator subunit 3 (pse3) as a..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of protein proteasome activator subunit 3 (pse3) as a... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1486930